Dr Charles S O'mara, MD | |
2500 N State St, Jackson, MS 39216-4500 | |
(601) 984-5105 | |
(601) 815-3322 |
Full Name | Dr Charles S O'mara |
---|---|
Gender | Male |
Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
Location | 2500 N State St, Jackson, Mississippi |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215088364 | NPI | - | NPPES |
0116204 | Medicaid | MS | |
753068151 | Other | MHP | |
753068151 | Other | UHC | |
753068151017 | Other | TRICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 09537 (Mississippi) | Primary |
Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
UNISON has welcomed the government's assurances over future NHS reform as a helpful blueprint for handling change.
Atrium Medical Corporation is proud to announce the release of the interim results from the COBEST clinical study. This study is to evaluate the use of bare metal stents vs. balloon expandable covered stents for the treatment of aorto-iliac occlusive disease. Prof. Patrice Mwipatayi of Royal Perth Hospital, Australia, presented interim data on the Covered versus Balloon Expandable Stent Trial known as COBEST at the 2009 VIVA (Vascular InterVentional Advances) meeting in Las Vegas.
Human papillomavirus (HPV) can infect the mouth and throat to cause cancers of the oropharynx. A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, has found that having more than 10 prior oral sex partners was associated with a 4.3-times greater likelihood of having HPV-related oropharyngeal cancer.
Researchers in the United States have developed a new automated approach to detecting variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – that have increased growth rates over other lineages.
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration approved JANUMET XR (sitagliptin and metformin hydrochloride extended-release) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of JANUVIA (sitagliptin), with extended-release metformin.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Charles S O'mara, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5105 | Dr Charles S O'mara, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5105 |
News Archive
UNISON has welcomed the government's assurances over future NHS reform as a helpful blueprint for handling change.
Atrium Medical Corporation is proud to announce the release of the interim results from the COBEST clinical study. This study is to evaluate the use of bare metal stents vs. balloon expandable covered stents for the treatment of aorto-iliac occlusive disease. Prof. Patrice Mwipatayi of Royal Perth Hospital, Australia, presented interim data on the Covered versus Balloon Expandable Stent Trial known as COBEST at the 2009 VIVA (Vascular InterVentional Advances) meeting in Las Vegas.
Human papillomavirus (HPV) can infect the mouth and throat to cause cancers of the oropharynx. A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, has found that having more than 10 prior oral sex partners was associated with a 4.3-times greater likelihood of having HPV-related oropharyngeal cancer.
Researchers in the United States have developed a new automated approach to detecting variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – that have increased growth rates over other lineages.
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration approved JANUMET XR (sitagliptin and metformin hydrochloride extended-release) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of JANUVIA (sitagliptin), with extended-release metformin.
› Verified 9 days ago
Dr. Richard P Cochran, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 406-640-4933 | |
Dr. Lawrence Lee Creswell, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5170 Fax: 601-984-5198 | |
Dr. Craig Vorpe Adams, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 501 Marshall St Ste 104, Jackson, MS 39202 Phone: 601-969-6404 Fax: 601-973-4541 | |
Dr. Ali Dodge-khatami, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 2500 N State St, Division Of Pediatric Cardiac Surgery, Jackson, MS 39216 Phone: 601-984-4693 | |
Dr. Albert Michael Koury, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 501 Marshall St, Suite 100, Jackson, MS 39202 Phone: 601-969-7467 Fax: 601-948-1417 | |
Mr. Fidel Fabian Sendra, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1860 Chadwick Dr Ste 256, Jackson, MS 39204 Phone: 601-376-1394 |